# Fluorodeoxyglucose Positron Emission Tomography (FDG PET) Findings in Patients With Phenylketonuria Before and After KUVAN Therapy

> **NCT00986973** · NA · COMPLETED · sponsor: **Children's Hospital of Philadelphia** · enrollment: 6 (actual)

## Conditions studied

- Phenylketonuria

## Interventions

- **DRUG:** Sapropterin

## Key facts

- **NCT ID:** NCT00986973
- **Lead sponsor:** Children's Hospital of Philadelphia
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03
- **Primary completion:** 2011-07
- **Final completion:** 2011-09
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2015-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00986973

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00986973, "Fluorodeoxyglucose Positron Emission Tomography (FDG PET) Findings in Patients With Phenylketonuria Before and After KUVAN Therapy". Retrieved via AI Analytics 2026-08-17 from https://api.ai-analytics.org/clinical/NCT00986973. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*